# Carbidopa-levodopa

NDC: 52817-392
Generic name: carbidopa and levodopa
Labeler / Manufacturer: TruPharma, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20220921

FDA application: ANDA216505

## Active ingredients

- CARBIDOPA: 25 mg/1
- LEVODOPA: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"52817-392"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=52817-392
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d1bb319b-82a3-4b66-9cdc-f77fdb8383ce